LinkOPH

MIAMI — Phase 3 PHOENIX study data show a strong anatomic benefit of conbercept treatment, an anti-VEGF developed in China, a speaker said here. “There is a strong benefit of conbercept treatment on anatomic outcomes that support the visual acuity results for neovascular AMD,” Ronald P. Danis, MD, said at the Angiogenesis, Exudation, and Degeneration 2014 meeting. Conbercept was approved for use in China for age-related macular degeneration in December.

Read more →

Full Story →

Read more →

SLACK Incorporated, publisher of Healio.com, has announced the launch of MedBlog, a new blog portal for all medical specialists on Healio.com.A single resource at Healio.com/blogs, MedBlog provides one place on Healio.com for physicians to see what their colleagues in other specialties are talking about today – and are invited to contribute to the conversations. Current topics range from clinical to regulatory to practice management.

Read more →

MIAMI — There is no clear evidence that aspirin use has a harmful effect on age-related macular degeneration, according to a speaker here.“Persons with AMD should consider aspirin therapy when medically indicated,” Emily Y. Chew, MD, said at the Angiogenesis, Exudation, and Degeneration 2014 meeting. Using data from the AREDS2, Chew and colleagues developed and analyzed propensity score data to study the question of whether taking aspirin has a harmful effect associated with AMD.

Read more →